Barth Jay 4

Accession 0001209191-20-042311

CIK 0001178879other

Filed

Jul 12, 8:00 PM ET

Accepted

Jul 13, 6:54 PM ET

Size

27.1 KB

Accession

0001209191-20-042311

Form 4

Period: 2020-07-09

Chief Medical Officer

Transactions

Exercise/Conversion
Stock Options (right to buy)
2020-07-09−6,142→ 55,099 total
Exercise: $10.04Exp: 2029-01-02→ Common Stock (6,142 underlying)
Exercise/Conversion
Common Stock
2020-07-09$12.28/sh+17,896$219,763→ 207,651 total
Exercise/Conversion
Common Stock
2020-07-10$5.13/sh+28,843$147,965→ 192,047 total
Exercise/Conversion
Stock Options (right to buy)
2020-07-09−8,850→ 0 total
Exercise: $9.03Exp: 2026-01-04→ Common Stock (8,850 underlying)
Exercise/Conversion
Stock Options (right to buy)
2020-07-10−28,843→ 11,778 total
Exercise: $5.13Exp: 2027-01-03→ Common Stock (28,843 underlying)
Sale
Common Stock
2020-07-10$15.65/sh−28,843$451,433→ 163,204 total
Exercise/Conversion
Stock Options (right to buy)
2020-07-09−17,896→ 0 total
Exercise: $12.28Exp: 2025-06-01→ Common Stock (17,896 underlying)
Sale
Common Stock
2020-07-09$15.92/sh−44,447$707,494→ 163,204 total
Exercise/Conversion
Common Stock
2020-07-09$9.03/sh+8,850$79,916→ 183,613 total
Exercise/Conversion
Common Stock
2020-07-09$8.61/sh+11,559$99,523→ 174,763 total
Exercise/Conversion
Common Stock
2020-07-09$10.04/sh+6,142$61,666→ 189,755 total
Exercise/Conversion
Stock Options (right to buy)
2020-07-09−11,559→ 0 total
Exercise: $8.61Exp: 2025-01-02→ Common Stock (11,559 underlying)

Holdings

Footnotes (6)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
[F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.90 to $15.98. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.49 to $15.91 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]All of the options were fully vested and exercisable as of the transaction date.
[F5]As of July 9, 2020, 9,584 options were fully vested and exercisable and 51,657 remained unvested from this grant.
[F6]As of July 10, 2020, 31,785 options were fully vested and exercisable and 8,836 remained unvested from this grant.

Documents

1 file

AMICUS THERAPEUTICS, INC.

CIK 0001178879

Entity typeother